Topical Products Recalled

News
Article

Ridge Properties LLC DBA Pain Relief Naturally is voluntarily recalling four lots of 4% lidocaine topical cream and liquid gel products due to microbiological contamination and incorrect potency.

Ridge Properties LLC DBA Pain Relief Naturally announced on Aug. 8, 2019 that it was voluntarily recalling four lots of 4% lidocaine topical cream and liquid gel products because FDA analysis found microbiological contamination and incorrect potency. According to FDA, the potency is higher than the label amount for lidocaine.

The recalled products include PreTAT, which is used as a numbing agent and topical anesthetic prior to the application of a tattoo. According to the company, use of contaminated product prior to receiving a tattoo could result in infection.

The company also states that using lidocaine that is more potent than intended “may increase the risk of methemoglobinemia, a blood disorder in which an abnormal amount of methemoglobin is produced.” 

According to the company, no adverse events have been reported. A complete list of recalled products may be found on FDA.gov. Adverse events may be reported through the agency’s MedWatch program.

Source: FDA

 

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content